MOLDTECH2024-10-012024-12-31 MOLDTECH2024-10-012024-12-31 MOLDTECH2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member MOLDTECH2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member MOLDTECH2024-12-31 MOLDTECH2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member MOLDTECH2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member MOLDTECH2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member MOLDTECH2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member MOLDTECH2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member MOLDTECH2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 526263 MOLDTECH NOTLISTED Mold-Tek Technologies Limited Equity 2024-04-01 2025-03-31 2025-02-12 2025-02-07 INR Lakhs Third quarter 11:30:00 15:00:00 2025-02-12 2025-02-12 Not applicable Single segment Structural Engineering and Design Services 2024-10-01 2024-12-31 Unaudited Consolidated 335989000.00 -2899000.00 333090000.00 0.00 0.00 0.00 266218000.00 1538000.00 15855000.00 42335000.00 325946000.00 7144000.00 0.00 7144000.00 1680000.00 45000.00 1725000.00 0.00 5419000.00 0.00 0.00 0.00 0.00 5419000.00 -16123000.00 -10704000.00 5419000.00 0.00 -10704000.00 0.00 57129000.00 2 0.19 0.19 0.00 0.00 0.19 0.19 Notes: 1 The above results for the quarter and nine months ended 31st December 2024 were reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting held on 12th February, 2025. 2 The above results include the results of the wholly owned subsidiary, Mold-Tek Technologies Inc, USA. 3 The Group has consolidated financial results based on Ind AS 110 Consolidated Financial Statements . 4 The Group has one reportable segment as per the requirements of ind AS 108 “Operating Segments . 5 This statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 6 The figures for the corresponding previous period have been regrouped/reclassified wherever necessary, to make them comparable. Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 1159725000.00 12887000.00 1172612000.00 0.00 0.00 0.00 793381000.00 5567000.00 50028000.00 140772000.00 989748000.00 182864000.00 0.00 182864000.00 46117000.00 -536000.00 45581000.00 0.00 137283000.00 0.00 0.00 0.00 0.00 137283000.00 -23839000.00 113444000.00 137283000.00 0.00 113444000.00 0.00 57129000.00 2 4.81 4.76 0.00 0.00 4.81 4.76 Other Expenses 42335000.00 Other Expenses 140772000.00 Remeasurment of defined benefit plans -1536000.00 Fair value changes in equity instruments -15241000.00 Remeasurment of defined benefit plans -4607000.00 Fair value changes in equity instruments -20011000.00 -16777000.00 -24618000.00 0.00 0.00 Exchange differences in translating the Financial Statements of a foreign operation 654000.00 Exchange differences in translating the Financial Statements of a foreign operation 779000.00 654000.00 779000.00 0.00 0.00